Phraction Management LLC Grows Stock Holdings in Danaher Co. (NYSE:DHR)

Phraction Management LLC grew its holdings in Danaher Co. (NYSE:DHR) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,062 shares of the conglomerate’s stock after acquiring an additional 607 shares during the period. Danaher comprises 3.0% of Phraction Management LLC’s holdings, making the stock its 14th biggest position. Phraction Management LLC’s holdings in Danaher were worth $8,508,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in DHR. Wedge Capital Management L L P NC boosted its holdings in Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after buying an additional 38 shares in the last quarter. Meridian Financial Partners LLC boosted its holdings in Danaher by 4.4% during the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after buying an additional 40 shares in the last quarter. Kovack Advisors Inc. boosted its holdings in Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after buying an additional 41 shares in the last quarter. Well Done LLC boosted its holdings in Danaher by 1.2% during the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock worth $987,000 after buying an additional 42 shares in the last quarter. Finally, Waypoint Capital Advisors LLC boosted its holdings in Danaher by 0.9% during the third quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after buying an additional 42 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent analyst reports. Wells Fargo & Company lowered their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Royal Bank of Canada restated an “outperform” rating and set a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. UBS Group reduced their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Finally, Stifel Nicolaus upped their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Price Performance

Danaher stock opened at $202.22 on Thursday. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The stock has a market cap of $146.06 billion, a P/E ratio of 38.30, a PEG ratio of 2.68 and a beta of 0.83. The company has a 50-day moving average price of $231.17 and a 200 day moving average price of $250.62. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 earnings per share. Sell-side analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.